Loading...
Header Logo
Keywords
Last Name
Institution

Connection

Doreen Brettler to Factor VIII

This is a "connection" page, showing publications Doreen Brettler has written about Factor VIII.

 
Connection Strength
 
 
 
1.613
 
  1. Brettler DB. Inhibitors in congenital haemophilia. Baillieres Clin Haematol. 1996 Jun; 9(2):319-29.
    View in: PubMed
    Score: 0.179
  2. Boylan B, Rice AS, Dunn AL, Tarantino MD, Brettler DB, Barrett JC, Miller CH. Characterization of the anti-factor VIII immunoglobulin profile in patients with hemophilia A by use of a fluorescence-based immunoassay. J Thromb Haemost. 2015 Jan; 13(1):47-53.
    View in: PubMed
    Score: 0.162
  3. Brettler D. A 3.5-year study of immune function in persons with hemophilia infusing recombinant factor VIII. Ann Hematol. 1994; 68 Suppl 3:S49-50.
    View in: PubMed
    Score: 0.152
  4. Brettler DB. Inhibitors of factor VIII: detection and treatment. Southeast Asian J Trop Med Public Health. 1993; 24 Suppl 1:21-5.
    View in: PubMed
    Score: 0.141
  5. Brettler DB. Comments on the development of inhibitor antibodies in patients using recombinant factor VIII concentrates. Semin Hematol. 1991 Apr; 28(2 Suppl 1):45-6.
    View in: PubMed
    Score: 0.125
  6. Brettler DB. Proposed protocol for the evaluation of the effect of high purity factor concentrates on the immune system of hemophilia patients. Thromb Haemost. 1989 Sep 29; 62(2):811-2.
    View in: PubMed
    Score: 0.113
  7. Brettler DB, Forsberg AD, Levine PH, Aledort LM, Hilgartner MW, Kasper CK, Lusher JM, McMillan C, Roberts H. The use of porcine factor VIII concentrate (Hyate:C) in the treatment of patients with inhibitor antibodies to factor VIII. A multicenter US experience. Arch Intern Med. 1989 Jun; 149(6):1381-5.
    View in: PubMed
    Score: 0.110
  8. Brettler DB, Forsberg AD, Levine PH, Petillo J, Lamon K, Sullivan JL. Factor VIII:C concentrate purified from plasma using monoclonal antibodies: human studies. Blood. 1989 May 15; 73(7):1859-63.
    View in: PubMed
    Score: 0.110
  9. Brettler DB, Forsberg AD, O'Connell FD, Cederbaum AI, Chaitman AK, Levine PH. A long-term study of hemophilic arthropathy of the knee joint on a program of Factor VIII replacement given at time of each hemarthrosis. Am J Hematol. 1985 Jan; 18(1):13-8.
    View in: PubMed
    Score: 0.081
  10. Engelfriet CP, Reesink HW, Mannucci PM, Gringeri A, Ingerslev J, Brettler DB, Mauser-Bunschoten EP, Negrier C, Berntorp E, Smith OP, Shapiro AD. The optimal treatment for haemophiliacs who have developed factor VIII or -IX antibodies. Vox Sang. 2000; 78(4):256-61.
    View in: PubMed
    Score: 0.057
  11. Shopnick RI, Brettler DB. Hemostasis: a practical review of conservative and operative care. Clin Orthop Relat Res. 1996 Jul; (328):34-8.
    View in: PubMed
    Score: 0.045
  12. Shopnick RI, Kazemi M, Brettler DB, Buckwalter C, Yang L, Bray G, Gomperts ED. Anaphylaxis after treatment with recombinant factor VIII. Transfusion. 1996 Apr; 36(4):358-61.
    View in: PubMed
    Score: 0.044
  13. Shopnick RI, Brettler DB, Bolivar E. Hepatitis C virus transmission by monoclonal purified viral-attenuated factor VIII concentrate. Lancet. 1995 Sep 2; 346(8975):645.
    View in: PubMed
    Score: 0.043
  14. Mannucci PM, Brettler DB, Aledort LM, Lusher JM, Abildgaard CF, Schwartz RS, Hurst D. Immune status of human immunodeficiency virus seropositive and seronegative hemophiliacs infused for 3.5 years with recombinant factor VIII. The Kogenate Study Group. Blood. 1994 Apr 1; 83(7):1958-62.
    View in: PubMed
    Score: 0.039
  15. Seremetis SV, Aledort LM, Bergman GE, Bona R, Bray G, Brettler D, Eyster ME, Kessler C, Lau TS, Lusher J, et al. Three-year randomised study of high-purity or intermediate-purity factor VIII concentrates in symptom-free HIV-seropositive haemophiliacs: effects on immune status. Lancet. 1993 Sep 18; 342(8873):700-3.
    View in: PubMed
    Score: 0.037
  16. Mannucci PM, Schimpf K, Abe T, Aledort LM, Anderle K, Brettler DB, Hilgartner MW, Kernoff PB, Kunschak M, McMillan CW, et al. Low risk of viral infection after administration of vapor-heated factor VIII concentrate. International Investigator Group. Transfusion. 1992 Feb; 32(2):134-8.
    View in: PubMed
    Score: 0.033
  17. Schwartz RS, Abildgaard CF, Aledort LM, Arkin S, Bloom AL, Brackmann HH, Brettler DB, Fukui H, Hilgartner MW, Inwood MJ, et al. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A. recombinant Factor VIII Study Group. N Engl J Med. 1990 Dec 27; 323(26):1800-5.
    View in: PubMed
    Score: 0.031
  18. Mannucci PM, Schimpf K, Brettler DB, Ciavarella N, Colombo M, Haschke F, Lechner K, Lusher J, Weissbach G. Low risk for hepatitis C in hemophiliacs given a high-purity, pasteurized factor VIII concentrate. International Study Group. Ann Intern Med. 1990 Jul 1; 113(1):27-32.
    View in: PubMed
    Score: 0.030
  19. Brettler DB, Brewster F, Levine PH, Forsberg A, Baker S, Sullivan JL. Immunologic aberrations, HIV seropositivity and seroconversion rates in patients with hemophilia B. Blood. 1987 Jul; 70(1):276-81.
    View in: PubMed
    Score: 0.024
  20. Brettler DB, Forsberg AD, Brewster F, Sullivan JL, Levine PH. Delayed cutaneous hypersensitivity reactions in hemophiliac subjects treated with factor concentrate. Am J Med. 1986 Oct; 81(4):607-11.
    View in: PubMed
    Score: 0.023
  21. Sullivan JL, Brewster FE, Brettler DB, Forsberg AD, Cheeseman SH, Byron KS, Baker SM, Willitts DL, Lew RA, Levine PH. Hemophiliac immunodeficiency: influence of exposure to factor VIII concentrate, LAV/HTLV-III, and herpesviruses. J Pediatr. 1986 Apr; 108(4):504-10.
    View in: PubMed
    Score: 0.022
  22. Goldsmith GH, Baily RG, Brettler DB, Davidson WR, Ballard JO, Driscol TE, Greenberg JM, Kasper CK, Levine PH, Ratnoff OD. Primary pulmonary hypertension in patients with classic hemophilia. Ann Intern Med. 1988 Jun; 108(6):797-9.
    View in: PubMed
    Score: 0.006
  23. Levine PH, Brettler DB, Sullivan JL. Hemophilia and acquired immune deficiency syndrome. Prog Clin Biol Res. 1985; 182:287-96.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.